Explore the Global Atrial Appendage Occluder Market— analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Atrial Appendage Occluder Market

Key Insight

Atrial appendage occluder sales will strengthen through 2036, anchored by endocardial devices at a 57.6% share, driven by demand for catheter-based LAA closure enabling percutaneous implantation. Atrial fibrillation associated stroke prevention leads with a 49.3% share. The market is set to reach USD 1.2 billion by 2026-end and USD 2.1 billion by 2036.

May 08, 2026

Anurag Sharma

306 Pages

Cite this Report

Atrial Appendage Occluder Market

https://www.futuremarketinsights.com/reports/atrial-appendage-occluder-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

Abbott Laboratories
Append Medical Ltd
Artiria Medical SA
Boston Scientific
Cardia Inc
Conformal Medical Inc
Lifetech Scientific Corp
Occlutech Holding AG

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Atrial Appendage Occluder Market

Key Players

Similar Industry Reports